clemastine has been researched along with ranitidine in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (22.73) | 18.7374 |
| 1990's | 4 (18.18) | 18.2507 |
| 2000's | 8 (36.36) | 29.6817 |
| 2010's | 4 (18.18) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Brendel, W; Conzen, PF; Gutmann, R; Habazettl, H; Hobbhahn, J; Peter, K; Vollmar, B; Yekebas, E | 1 |
| Nicholson, AN | 1 |
| Bommer, M; Herz, A; Liebisch, D; Noble, EP | 1 |
| Bommer, M; Herz, A; Kley, N; Liebisch, D; Noble, E | 1 |
| Browne, PD; Kirby, JD; Meyrick Thomas, RH | 1 |
| Browne, PD; Kirby, JD; Thomas, RH | 1 |
| Heyneman, CA | 1 |
| Iro, H; Krause, J; Leuwer, A; Waldfahrer, F | 1 |
| Diergarten, K; Goes-Schmieder, R; Kober, B; Kolotas, C; Martin, T; Mitrou, PS; Schneider, LV; Vogt, HG; Zamboglou, N | 1 |
| Heymanns, J; Köppler, H; Weide, R | 1 |
| Cassuto, J; Räntfors, J | 1 |
| den Bakker, MA; Gelderblom, H; Kloover, JS; van Meerbeeck, JP | 1 |
| Oosterloo, M; ter Maaten, JC | 1 |
| Branga, P; Coelho, D; Fernandes, T; Malheiro, D; Rodrigues, J | 1 |
| Erdmann, U; Guthke, K; Klein, U; Laubinger, R | 1 |
| Boere, IA; Bosch, TM; Cox, JM; Jager, A; Malmberg, R; Mathijssen, RHJ; Oomen-de Hoop, E; van den Bemt, PMLA; van Doorn, L; van Leeuwen, RWF | 1 |
2 review(s) available for clemastine and ranitidine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Histamine2-antagonists in allergic disorders.
Topics: Asthma; Chlorpheniramine; Cimetidine; Clemastine; Clinical Trials as Topic; Drug Therapy, Combination; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Hypersensitivity; Male; Nasal Decongestants; Ranitidine; Rhinitis, Allergic, Perennial | 1994 |
4 trial(s) available for clemastine and ranitidine
| Article | Year |
|---|---|
The effect of ranitidine, alone and in combination with clemastine, on allergen-induced cutaneous wheal-and-flare reactions in human skin.
Topics: Adolescent; Adult; Allergens; Child; Clemastine; Drug Therapy, Combination; Humans; Hypersensitivity, Immediate; Pyrrolidines; Ranitidine; Skin; Skin Tests | 1985 |
Paclitaxel and simultaneous radiation in locally advanced stage IIIA/B non-small cell lung cancer: a clinical phase I study.
Topics: Adult; Aged; Anti-Allergic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Clemastine; Combined Modality Therapy; Dexamethasone; Drug Administration Schedule; Drug Hypersensitivity; Drug Tolerance; Female; Histamine H2 Antagonists; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Premedication; Radiation-Sensitizing Agents; Radiotherapy Dosage; Ranitidine; Remission Induction; Treatment Outcome | 1996 |
Dose reduction of steroid premedication for paclitaxel: no increase of hypersensitivity reactions.
Topics: Adult; Aged; Aged, 80 and over; Anaphylaxis; Clemastine; Dexamethasone; Dose-Response Relationship, Drug; Drug Hypersensitivity; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Paclitaxel; Premedication; Ranitidine; Treatment Outcome | 2001 |
The added value of H
Topics: Adult; Aged; Aged, 80 and over; Chemoprevention; Clemastine; Dexamethasone; Drug Hypersensitivity; Drug Therapy, Combination; Equivalence Trials as Topic; Female; Histamine H2 Antagonists; Humans; Infusions, Intravenous; Male; Medical Futility; Middle Aged; Neoplasms; Netherlands; Paclitaxel; Premedication; Ranitidine; Severity of Illness Index; Treatment Outcome | 2021 |
16 other study(ies) available for clemastine and ranitidine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Pulmonary hypertension after heparin-protamine: roles of left-sided infusion, histamine, and platelet-activating factor.
Topics: Animals; Azepines; Clemastine; Hemodynamics; Heparin Antagonists; Hypertension, Pulmonary; Platelet Activating Factor; Protamines; Ranitidine; Swine; Triazoles | 1990 |
Central effects of H1 and H2 antihistamines.
Topics: Aerospace Medicine; Benzhydryl Compounds; Central Nervous System; Chlorpheniramine; Cimetidine; Clemastine; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Phenothiazines; Promethazine; Psychomotor Performance; Ranitidine; Sleep Stages; Structure-Activity Relationship; Terfenadine; Visual Acuity; Visual Perception | 1985 |
H1-histaminergic activation of catecholamine release by chromaffin cells.
Topics: Adrenal Medulla; Animals; Biological Transport, Active; Calcium; Catecholamines; Cattle; Cells, Cultured; Cimetidine; Clemastine; Histamine; Hormones; Kinetics; Muscarine; Nicotine; Norepinephrine; Ranitidine; Receptors, Histamine; Receptors, Histamine H1 | 1988 |
Histamine affects release and biosynthesis of opioid peptides primarily via H1-receptors in bovine chromaffin cells.
Topics: Adrenal Glands; Animals; Calcium; Cattle; Cells, Cultured; Chromaffin System; Cimetidine; Clemastine; Cobalt; Enkephalin, Leucine; Enkephalin, Methionine; Enkephalins; Gallopamil; Histamine; Histamine Antagonists; Nifedipine; Protein Precursors; Pyrilamine; Ranitidine; Receptors, Histamine; Receptors, Histamine H1; RNA, Messenger | 1987 |
The influence of ranitidine, alone and in combination with clemastine, on histamine-mediated cutaneous weal and flare reactions in human skin.
Topics: Adult; Clemastine; Double-Blind Method; Histamine; Histamine Antagonists; Humans; Pyrrolidines; Ranitidine; Receptors, Histamine H2; Skin; Skin Tests | 1985 |
[Severe oropharyngeal angioedema caused by ACE inhibitor. A case report].
Topics: Angioedema; Clemastine; Clonidine; Combined Modality Therapy; Drug Hypersensitivity; Emergencies; Enalapril; Humans; Hypertension, Renal; Laryngeal Edema; Male; Middle Aged; Prednisolone; Ranitidine; Tracheotomy | 1995 |
Role of histamine receptors in the regulation of edema and circulation postburn.
Topics: Animals; Burns; Clemastine; Edema; Histamine Agonists; Histamine H1 Antagonists; Histamine H2 Antagonists; Imidazoles; Male; Piperidines; Ranitidine; Rats; Rats, Sprague-Dawley; Receptors, Histamine; Receptors, Histamine H3; Regional Blood Flow; Skin; Statistics, Nonparametric; Thiourea | 2003 |
Fatal outcome of a hypersensitivity reaction to paclitaxel: a critical review of premedication regimens.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clemastine; Dexamethasone; Drug Hypersensitivity; Fatal Outcome; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Ranitidine; Risk Factors | 2004 |
[Diagnostic image (283). A man with a swollen tongue].
Topics: Aged; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Clemastine; Humans; Male; Prednisone; Ranitidine; Tongue Diseases; Treatment Outcome | 2006 |
Intraoperative anaphylaxis after intravenous atropine.
Topics: Adjuvants, Anesthesia; Aged; Anaphylaxis; Anesthesia, General; Anti-Inflammatory Agents; Atropine; Blood Pressure; Cholinesterase Inhibitors; Clemastine; Elective Surgical Procedures; Heart Rate; Histamine Antagonists; Humans; Hydrocortisone; Injections, Intravenous; Intraoperative Complications; Lumbar Vertebrae; Male; Neostigmine; Norepinephrine; Ranitidine; Skin Tests; Vasoconstrictor Agents | 2007 |
[Angioneurotic orolingual edema associated with the use of rt-PA following a stroke].
Topics: Angioedema; Angiotensin-Converting Enzyme Inhibitors; Clemastine; Complement C1s; Edema; Female; Fibrinolytic Agents; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Middle Aged; Neurologic Examination; Ranitidine; Recombinant Proteins; Stroke; Tissue Plasminogen Activator; Tongue Diseases | 2007 |